TrialGynecologic oncology2024

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer.

Sarah Andres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.